| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Avicursen | TV-1102; ATL/TV-1102; ATL-1102; ISIS-107248 | Phase 2 Clinical | Ionis Pharmaceuticals Inc | Multiple Sclerosis; Muscular Dystrophy, Duchenne | Details |
| BIIB-107 (Biogen) | BIIB-107 | Phase 1 Clinical | Biogen Inc | Multiple Sclerosis | Details |
| ELND-004 | ELND-004 | Phase 1 Clinical | Perrigo Company Plc | Autoimmune Diseases | Details |